Description
LGD 3303 is a research compound being investigated for its potential to selectively bind to androgen receptors in muscles and bones, which may provide a safer treatment for osteoporosis than current medications. Studies have found LGD-3303 to be a powerful and highly selective androgen receptor agonist in skeletal muscle, while being a much weaker partial agonist in sebaceous glands and prostate.
| LGD 3303 | |
| CAS Number | 917891-35-1, 1196133-39-7 |
| Molar Mass | 342.75 g·mol−1 |
| Chemical Formula | C16H14ClF3N2O |
| IUPAC Name | 9-chloro-2-ethyl-1-methyl-3-(2,2,2-trifluoroethyl)-3H,6H,7H-pyrrolo[3,2-f]quinolin-7-one |
Reviews
There are no reviews yet.